PSAMP
PROK icon

P. Schoenfeld Asset Management (PSAM)’s ProKidney PROK Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-122,379
Closed -$1.22M – 312
2022
Q2 		$1.22M Sell
122,379
-22,155
-15% -$219K 0.07% 198
2022
Q1 		$1.43M Hold
144,534
– – 0.07% 219
2021
Q4 		$1.43M Buy
144,534
+44,534
+45% +$440K 0.07% 217
2021
Q3 		$980K Buy
+100,000
New +$985K 0.06% 214

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s PROK Position: Q3 2022 in Review

P. Schoenfeld Asset Management (PSAM) sold out of ProKidney (PROK) in Q3 2022, closing a stake of 122,379 shares — an estimated $1.22M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in PROK in Q3 2021 and held it in 4 quarters. The position peaked at $1.43M in Q1 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 122,379 ProKidney shares in Q3 2022, an estimated $1.22M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in ProKidney in Q3 2021 and held it in 4 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s ProKidney position peaked at $1.43M in Q1 2022.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q3 2022, filed 14 Nov 2022.